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Risk stratiﬁcation strategies used in the diagnosis
and management of coronary artery disease (CAD) aim
to identify patients with intermediate to high likelihood
of signiﬁcant CAD that might beneﬁt from coronary
revascularizations and/or aggressive medical therapy.
Myocardial perfusion imaging (MPI) has been an inte-
gral part of the traditional risk stratiﬁcation algorithm
for more than two decades. While the presence of sig-
niﬁcant ischemia on MPI usually necessitates further
evaluation with coronary catheterization, patients with
normal or low risk scans are mostly managed medically.
Even though a normal MPI result generally indicates a
benign prognosis, the ‘‘warranty period’’ of such result
could be substantially shorter in patients with certain
clinical risk factors such as adenosine stress (due to
inability to exercise), increasing age, diabetes, female
gender in diabetics, and history of known CAD indi-
cating a lower negative predictive value for MPI in this
subset of high risk patients.
1,2
Imaging modalities such as coronary artery calcium
scanning (CACS) and coronary CT angiography (CTA)
provide information about the coronary anatomy and
histology rather than the coronary function. Coronary
artery calcium is a marker of vascular injury and its
amount (CACS) correlates closely with atherosclerotic
burden.
3,4 Along its comparable diagnostic accuracy in
prediction of signiﬁcant CAD, CACS has also been
shown to have signiﬁcant incremental prognostic value
over MPI in several recent studies suggesting a strong
potential for its complementary use with MPI.
5,6 On the
other hand, CTA has proven to provide highly accurate
diagnosis of obstructive coronary plaques signiﬁcantly
outperforming MPI in all of the studies.
7-9 CTA also
presents more deﬁnitive information about the stage of
atherosclerotic process by further characterizing the
plaques as non-calciﬁed (soft), mixed or calciﬁed, which
may also add more value in the prognostication of CAD.
There is already some early evidence to support this
independent incremental prognostic value for CTA over
MPI.
10,11 It also seems that traditional clinical risk
assessment tools of Framingham Risk Score and Adult
Treatment Panel III (ATP III) alone cannot accurately
predict the atherosclerotic plaque burden as determined
by CTA.
12 This indicates CTA can identify a distinct
subset of patients who would have been misdiagnosed as
low risk for CAD by simply relying on their normal MPI
result or on their traditional cardiac risk factors taking a
further step in the risk stratiﬁcation and optimal man-
agement of these patients.
The prospective study of Choudhary et al which is
published in the current issue of the Journal addressed
exactly the above-mentioned issue of further risk strat-
iﬁcation of patients with normal MPI scans who might
beneﬁt from aggressive medical therapy using CACS
and CTA.
13 The patient population included 81 mostly
symptomatic (81%) patients (only three of them women)
with mean age of 60.4 ± 9.6 years and without prior
history of CAD or abnormal stress test who had normal
results on stress MPI [either by exercise (48 patients) or
dobutamine (33 patients) stress protocols]. All of the
patients underwent CACS and 16-slice CTA within 2 to
4 weeks of the MPI. Cardiac risk estimates by ATP III
criteria and post-MPI probability of CAD were also
calculated for each patient. As a result of the study, 43
patients (53% of all patients) were identiﬁed as candi-
dates for aggressive medical therapy using a post-test
risk stratiﬁcation model which classiﬁed patients as
having a high risk, when at least one the following three
conditions was present: either diabetes or ATP III
10 year-risk estimate of [20%; CACS[400; or coro-
nary stenosis of[50% on CTA. While only one of these
criteria was met in 29 patients, 7 patients shared all of
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13the three criteria and another 14 had both high CACS
and signiﬁcant stenosis on CTA. Lowering the cutoff
value of CACS to 100 resulted in almost complete
detection (sensitivity 96%) of patients with [50% ste-
nosis on CTA, but lowered the speciﬁcity from 91% to
61%. CTA provided further incremental risk stratiﬁca-
tion over CACS in nine patients who had[50% stenosis
on CTA and CACS of\400. However, the most striking
of all ﬁndings was that MPI failed to identify 28% of
patients with signiﬁcant obstructive stenosis on CTA in
a mostly symptomatic cohort of patients with predomi-
nantly intermediate to high 10-year risk for cardiac
events.
Authors went further and designed a risk stratiﬁ-
cation algorithm based on their ﬁndings, which aimed to
provide more optimal utilization of these prognostic
modalities. The ﬁrst step of their algorithm required
identiﬁcation of patients with diabetes and high ATP III
risk scores ([20%) which would directly qualify for
aggressive medical therapy. Further risk stratiﬁcation
with CACS was proposed for patients with either
intermediate ATP III risk score (10-20%) or intermedi-
ate post-test probability. Those with CACS above 400
would be directed to aggressive medical treatment arm
and those with CACS in the range of 100 to 399 would
be referred for further evaluation by CTA. At the ﬁnal
step patients with [50% coronary stenosis on CTA
would be identiﬁed as high risk and treated aggressively
with plaque stabilizing medical therapy.
This is an important study that highlights the limi-
tation of MPI in deﬁning patients who might beneﬁt from
further therapy and close outpatient monitoring. These
ﬁndings are in concordance with the fact that changes in
the coronary anatomy and histology always precede
myocardial ischemia. Consequently, lack of ischemia
does not necessarily preclude the presence of signiﬁcant
atherosclerotic burden. Moreover, myocardial ischemia
can be considered as a late sign in the atherosclerotic
process, correction of which does not really result in a
permanent ‘‘cure’’. Hence, it is important to look for
ways of early detection and treatment of patients with
atherosclerosis long before the occurrence of myocardial
ischemia. Thus, the ﬁndings of the present study should
promote further quest for more optimal post-MPI risk
stratiﬁcation and management algorithms.
Even though, the overall structure of the proposed
risk stratiﬁcation algorithm seems to be quite reason-
able, it should also be stressed on the point that the
management of symptomatic patients with normal
MPI results does not necessarily have to be limited
solely to medical therapy. With the addition of CTA
to the algorithm, clinicians should feel conﬁdent
enough to pursue further invasive imaging by coronary
catheterization, especially if anti-anginal therapy proves
to be insufﬁcient in patients with symptoms and
[50% stenosis on CTA. After all, symptomatic relief
is one of the few undisputable beneﬁts of coronary
revascularization.
Despite it is conceivable that based on the available
evidence presented at recently published trials the
assumptions about the high risk criteria used in the
proposed post-test risk stratiﬁcation algorithm must be
theoretically correct, they still need to be validated in
larger scale randomized prognostic studies testing for
this particular algorithm. Moreover, further research is
also needed to accurately determine the ‘‘warranty’’
period of a normal MPI in different risk groups of
patients, so that the patients who might need closer
monitoring and re-assessment by either repeated MPI
testing or other imaging modalities can be accurately
determined.
It is also worthwhile mentioning the limitations of
this study that might prevent the generalization of its
ﬁndings. First, this was a single-center study in which
the participants were referred for stress MPI by a multi-
specialty group of physicians. As the investigators also
noted, this practice pattern might not exactly reﬂect the
common type of medical management applied to the
general population. Second, the number of patients in
this cohort was relatively small requiring caution in
interpretation of results. There was also a marked gender
imbalance, so that women constituted less than 4% of
the population, limiting the applicability of the conclu-
sions only to men. The exclusion of patients with prior
history of CAD from the study was appropriate because
that group of patients is expected by all means to be
managed with aggressive medical therapy regardless of
the MPI result.
In conclusion, the ﬁndings of this study show that a
normal MPI result is not the end of the road for risk
stratiﬁcation of patients with symptoms. Substantial
portion of patients could still be categorized as high risk
based on the presence of diabetes, high 10-year risk on
ATP III, CAC score[400 or a[50% coronary stenosis
on CTA. Further research is needed to deﬁne the most
appropriate risk stratiﬁcation algorithm that would uti-
lize the best of the qualities of each risk assessment tool
and imaging modality in most optimal order.
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